Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BICYCLE THERAPEUTICS PLC Director's Dealing 2019

May 31, 2019

32777_dirs_2019-05-30_813acfec-1757-407d-8d74-350f1a727037.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2019-05-28

Reporting Person: Winter Gregory Paul (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-05-28 Ordinary Shares C 42870 Acquired 92477 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-28 Series A Preferred Shares $ C 42870 Disposed Ordinary Shares (42870) Direct

Footnotes

F1: Each Series A Preferred Share automatically converted into Ordinary Shares on a one-for-1.429 basis upon the closing of the Issuer's initial public offering and had no expiration date.